Community 365 Roundtable Meeting on Inequalities

The Community 365 Roundtable Meeting on Inequalities, focused on the East-West Divide and Treating Ageing Patients with Cancer, held on an invitation-only basis, brought together leading policy-makers, politicians, oncology experts and patient advocates to discuss these two important topics in the weeks before Europe‚Äôs Beating Cancer Plan is launched in December. 


The meeting video recording, presentation slides, as well as more details about the Programme and Speakers are provided on this page.  

 

community365 logo 447x350                                                             ineqv2

14 October 2020 14:00 - 16:30 CEST

Virtual Event

Community 365 is a group of charity, philanthropy and industry contributors to the Focused Topic Networks of the European Cancer Organisation, as part of our Strategy 2020-2023.  Community 365 provide ideas, guidance, practical support and resources for our work in convening stakeholders and building consensus in the European Cancer community.

 

For our first Community 365 Roundtable meeting, the topic of Inequalities was chosen, not least because of the importance placed on the subject by the EU Health Commissioner, Stella Kyriakides, in previous meetings with our Member Societies and Patient Advocacy Committee on the forthcoming Beating Cancer Plan.

Our President, Matti Aapro, will co-chair the meeting in two parts, together with Community 365 Contributor representatives and will include interventions from Sandra Gallina, Director-General at DG Sante, Enrique Soto, Older Adults Task Force of the American Society of Clinical Oncology and Kathy Oliver, Vice-Chair of our Patient Advisory Committee:

  • Treating Ageing Patients with Cancer from 14:00-15:15, to be co-chaired with Hampton Shaddock, Head of Global Public Affairs, Oncology, Sanofi
  • The East-West Divide from 15:15-16:30, to be co-chaired with Linda Gibbs, Oncology Lead for Central/Eastern Europe, Pfizer

There will be opportunity for delegates to comment and contribute during each session.  A Case for Action on Inequalities will be published after this Roundtable Meeting, based on the discussions and on the priorities of our Inequalities Network which includes the East-West Divide; Inequalities based on Gender, Ethnicity and Age; plus other Marginalised and Neglected Patient Groups.

The full programme is as follows:

Treating Ageing Patients with Cancer

14:00-14:10   Welcome & Overview

Dr Matti Aapro, President of the European Cancer Organisation & EU Cancer Mission Assembly Member

14:10-14:30    Ageing with Cancer: Impacts on Health Systems

Peter Lindgren, Managing Director, The Swedish Institute for Health Economics

Including a Question & Answer session

14:30-14:50   Challenges of Treating Ageing Patients: Overcoming Barriers

Professor Etienne Brain, Co-Chair Corporate Relations Committee for SIOG and Department of Clinical Research & Medical Oncology, Institut Curie

Including a Question & Answer session

14:50-15:10   Developing Policy to Support Ageing Patients with Cancer

Dr Cary Adams, Chief Executive Officer, Union for International Cancer Control

Including a Question & Answer session

15:10-15:15     Closing Remarks and Conclusions

Matti Aapro & Hampton Shaddock

 

The East-West Divide

15:15-15:20    Welcome & Overview

Dr Matti Aapro, President of the European Cancer Organisation & EU Cancer Mission Assembly Member

15:20-15:45   Deploying Cancer Intelligence to Inform our Priorities in Eastern European Countries

Including a presentation from Professor Mark Lawler (European Cancer Organisation Board Member; Associate Pro-Vice Chancellor and Professor of Digital Health, Queen's University Belfast)

And a Question & Answer session

15:45-16:25   Catalysing Action to Advance Cancer Care: Learnings from the Field

Veronique Trillet-Lenoir MEP, Rapporteur, Special Committee on Beating Cancer; Shadow Rapporteur, EU4Health; Member, EU Special Committee on Beating Cancer; Member, ENVI Committee and Co-Chair of MEPs Against Cancer and an Oncologist herself, moderates a discussion on best practice and experience from Croatia, Slovenia and Poland as examples.

Including presentations from:

Professor Tit Albreht,  Senior Health Services & Health Systems Researcher, National Institute Of Public Health Of Slovenia

Professor Piotr Rutkowski, Professor, Surgical Oncology, Maria Sklodowska-Curie National Research Institute Of Oncology

Professor Eduard Vrdoljak, Head, Center For Oncology & Professor, Faculty Of Medicine, University Of Split

16:25-16:30   Closing Remarks and Conclusions

Linda Gibbs, Oncology Lead for Central/Eastern Europe, Pfizer

Including update on Case for Action on Inequalities to be published and the European Cancer Summit session on Inequalities, presented by Nicolo Battisti & Hendrik Van Poppel, Co-Chairs of the Inequalities Network.

Speakers

  • Sandra Gallina Director-General, DG SANTE
  • Veronique Trillet-Lenoir MEP Rapporteur, Special Committee on Beating Cancer, Shadow Rapporteur, EU4Health; Member, EU Special Committee on Beating Cancer; Member, ENVI Committee and Co-Chair of MEPs Against Cancer, Oncologist
  • Cary Adams CEO, Union for International Cancer Control
  • Tit Albreht Senior Health Services and Health Systems Researcher, National Institute of Public Health of Slovenia
  • Etienne Brain Medical Oncologist, Department of Medical Oncology, Institut Curie
  • Mark Lawler European Cancer Organisation Board Member; Associate Pro-Vice Chancellor and Professor of Digital Health, Queen's University Belfast

Speakers

  • Sandra Gallina Director-General, DG SANTE
  • Veronique Trillet-Lenoir MEP Rapporteur, Special Committee on Beating Cancer, Shadow Rapporteur, EU4Health; Member, EU Special Committee on Beating Cancer; Member, ENVI Committee and Co-Chair of MEPs Against Cancer, Oncologist
  • Cary Adams CEO, Union for International Cancer Control
  • Tit Albreht Senior Health Services and Health Systems Researcher, National Institute of Public Health of Slovenia
  • Etienne Brain Medical Oncologist, Department of Medical Oncology, Institut Curie
  • Mark Lawler European Cancer Organisation Board Member; Associate Pro-Vice Chancellor and Professor of Digital Health, Queen's University Belfast
  • Sandra Gallina Director-General, DG SANTE
  • Veronique Trillet-Lenoir MEP Rapporteur, Special Committee on Beating Cancer, Shadow Rapporteur, EU4Health; Member, EU Special Committee on Beating Cancer; Member, ENVI Committee and Co-Chair of MEPs Against Cancer, Oncologist
  • Cary Adams CEO, Union for International Cancer Control
  • Tit Albreht Senior Health Services and Health Systems Researcher, National Institute of Public Health of Slovenia
  • Etienne Brain Medical Oncologist, Department of Medical Oncology, Institut Curie
  • Mark Lawler European Cancer Organisation Board Member; Associate Pro-Vice Chancellor and Professor of Digital Health, Queen's University Belfast
  • Peter Lindgren Managing Director of the Swedish Institute for Health Economics (IHE)
  • Piotr Rutkowski Professor, Surgical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology
  • Eduard Vrdoljak Head, Center for Oncology and Professor, Faculty of Medicine, University of Split
  • Matti Aapro President, European Cancer Organisation and EU Cancer Mission Assembly Member
  • Linda Gibbs Oncology Lead for Central/Eastern Europe, Pfizer
  • Hampton Shaddock Head of Global Public Affairs, Oncology, Sanofi
  • Nicolo Battisti European Cancer Organisation Inequalities Network Co-Chair
  • Hendrik Van Poppel European Cancer Organisation Inequalities Network Co-Chair
  • Kathy Oliver Vice-Chair of Patient Advisory Committee, European Cancer Organisation
  • Enrique Soto Older Adults Task Force of the American Society of Clinical Oncology

Speakers

  • Sandra Gallina Director-General, DG SANTE
  • Veronique Trillet-Lenoir MEP Rapporteur, Special Committee on Beating Cancer, Shadow Rapporteur, EU4Health; Member, EU Special Committee on Beating Cancer; Member, ENVI Committee and Co-Chair of MEPs Against Cancer, Oncologist
  • Cary Adams CEO, Union for International Cancer Control
  • Tit Albreht Senior Health Services and Health Systems Researcher, National Institute of Public Health of Slovenia
  • Etienne Brain Medical Oncologist, Department of Medical Oncology, Institut Curie
  • Mark Lawler European Cancer Organisation Board Member; Associate Pro-Vice Chancellor and Professor of Digital Health, Queen's University Belfast

Speakers

  • Sandra Gallina Director-General, DG SANTE
  • Veronique Trillet-Lenoir MEP Rapporteur, Special Committee on Beating Cancer, Shadow Rapporteur, EU4Health; Member, EU Special Committee on Beating Cancer; Member, ENVI Committee and Co-Chair of MEPs Against Cancer, Oncologist
  • Cary Adams CEO, Union for International Cancer Control
  • Tit Albreht Senior Health Services and Health Systems Researcher, National Institute of Public Health of Slovenia
  • Etienne Brain Medical Oncologist, Department of Medical Oncology, Institut Curie
  • Mark Lawler European Cancer Organisation Board Member; Associate Pro-Vice Chancellor and Professor of Digital Health, Queen's University Belfast